NASDAQ:SLNO

Soleno Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy SLNO

*Your capital is at risk

$53.01

+0 (+0%)

At Close: Jun 23, 2026

Soleno Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -64.72. In total, the insiders bought 558.46K and sold 2.5M SLNO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-64.72
● Buy	558.46K shares
● Sell	2.5M shares
19% Buy Activity Weak Negative Correlation
Sell Signal High Confidence May 18, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -64.72. Confidence increased due to high data reliability score of 100. Supported by overwhelming sell-side pressure (19% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 27, 2026 Sell	Common Stock S-Sale	Manning Meredith Chief Commercial Officer	Officer	558 Value: $17.7K
Mar 27, 2026 Sell	Common Stock S-Sale	Manning Meredith Chief Commercial Officer	Officer	4 864 Value: $146.1K
Mar 02, 2026 Buy	Employee stock option (right to buy) M-Exempt	Fulk Jennifer Chief Financial Officer	C-Suite Officer	67 660 Value: $2.64M
Mar 02, 2026 Buy	Common Stock J-Other	Fulk Jennifer Insider	Other	0 Value: $0
Mar 02, 2026 Buy	Common Stock A-Award	Fulk Jennifer Chief Financial Officer	C-Suite Officer	39 200 Value: $1.53M
Jan 21, 2026 Buy	Common Stock A-Award	Mackaness James H Chief Financial Officer	C-Suite Officer	28 600 Value: $1.25M
Jan 21, 2026 Buy	Employee stock option (right to buy) A-Award	Norrett Kevin Chief Business Officer	Officer	4 000 Value: $174.6K
Jan 21, 2026 Buy	Common Stock A-Award	Yen Kristen See Remarks	Officer	10 400 Value: $453.0K
Jan 21, 2026 Buy	Common Stock A-Award	Joshi Manher Chief Development Officer	Officer	4 100 Value: $178.6K
Jan 21, 2026 Buy	Common Stock A-Award	Manning Meredith Chief Commercial Officer	Officer	28 600 Value: $1.25M
Jan 21, 2026 Buy	Common Stock A-Award	Norrett Kevin Chief Business Officer	Officer	3 500 Value: $152.5K
Jan 21, 2026 Buy	Employee stock option (right to buy) A-Award	Mackaness James H Chief Financial Officer	C-Suite Officer	32 800 Value: $1.43M
Jan 21, 2026 Buy	Common Stock A-Award	Huang Michael F. Sr. Vp Of Clinical Development	Officer	10 400 Value: $453.0K
Jan 21, 2026 Buy	Common Stock A-Award	Hirano Patricia C See Remarks	Officer	10 400 Value: $453.0K
Jan 21, 2026 Buy	Common Stock A-Award	Anish Bhatnagar Chief Executive Officer	CEO / President	114 200 Value: $4.97M
Jan 21, 2026 Buy	Employee stock option (right to buy) A-Award	Anish Bhatnagar Chief Executive Officer	CEO / President	131 400 Value: $5.74M
Jan 21, 2026 Buy	Employee stock option (right to buy) A-Award	Hirano Patricia C See Remarks	Officer	11 900 Value: $519.4K
Jan 21, 2026 Buy	Employee stock option (right to buy) A-Award	Huang Michael F. Sr. Vp Of Clinical Development	Officer	11 900 Value: $519.4K
Jan 21, 2026 Buy	Employee stock option (right to buy) A-Award	Joshi Manher Chief Development Officer	Officer	4 700 Value: $205.2K
Jan 21, 2026 Buy	Employee stock option (right to buy) A-Award	Manning Meredith Chief Commercial Officer	Officer	32 800 Value: $1.43M
Jan 21, 2026 Buy	Employee stock option (right to buy) A-Award	Yen Kristen See Remarks	Officer	11 900 Value: $519.4K
Dec 15, 2025 Sell	Common Stock F-InKind	Hirano Patricia C See Remarks	Officer	904 Value: $45.2K
Dec 15, 2025 Sell	Common Stock F-InKind	Manning Meredith Chief Commercial Officer	Officer	1 922 Value: $96.0K
Dec 15, 2025 Sell	Common Stock F-InKind	Yen Kristen See Remarks	Officer	904 Value: $45.2K
Dec 15, 2025 Sell	Common Stock F-InKind	Huang Michael F. Sr. Vp Of Clinical Development	Officer	812 Value: $40.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks